Gilead Sciences Debt To Equity Over Time
| GILD Stock | USD 111.53 0.50 0.45% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Gilead Sciences Performance and Gilead Sciences Correlation. Gilead |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.258 | Dividend Share 3.08 | Earnings Share 0.38 | Revenue Per Share | Quarterly Revenue Growth 0.064 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Debt To Equity Analysis
Compare Gilead Sciences and related stocks such as Amgen Inc, Merck Company, and AbbVie Inc Debt To Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGN | 0.1104 | 1.1261 | 1.3919 | 1.454 | 1.1915 | 1.1237 | 1.158 | 1.4002 | 2.7143 | 3.0914 | 3.5058 | 4.9715 | 10.6378 | 10.3679 | 10.2261 | 10.74 |
| MRK | 0.1901 | 0.3213 | 0.3879 | 0.5036 | 0.44 | 0.5935 | 0.6197 | 0.7109 | 0.9406 | 1.0169 | 1.2557 | 0.8669 | 0.6673 | 0.9651 | 0.87 | 0.91 |
| ABBV | 0.004 | 0.004 | 4.6601 | 3.2776 | 8.5976 | 8.0281 | 7.9469 | 7.3314 | (4.7727) | (8.1654) | 6.5812 | 4.9769 | 3.667 | 5.7321 | 20.1937 | 21.2 |
| JNJ | 0.435 | 0.3439 | 0.3852 | 0.3852 | 0.3852 | 0.3852 | 0.3852 | 0.5748 | 0.5161 | 0.5161 | 0.5161 | 0.5161 | 0.5161 | 0.4265 | 0.38 | 0.36 |
| BMY | 0.146 | 0.3441 | 0.5428 | 0.5503 | 0.5273 | 0.4689 | 0.4147 | 0.6781 | 0.5238 | 0.9213 | 1.3662 | 1.2685 | 1.3109 | 1.4089 | 3.1344 | 3.29 |
| PFE | 0.174 | 0.4739 | 0.461 | 0.4782 | 0.5145 | 0.6023 | 0.7068 | 0.5975 | 0.6508 | 0.8258 | 0.6052 | 0.4792 | 0.3645 | 0.7959 | 0.72 | 0.75 |
| LLY | 0.0999 | 0.516 | 0.3746 | 0.2957 | 0.5241 | 0.5475 | 0.7357 | 1.1773 | 1.0478 | 6.0623 | 2.9416 | 1.8804 | 1.5248 | 2.3418 | 2.3493 | 2.47 |
| AZN | 6.0912 | 0.4013 | 0.4343 | 0.4468 | 0.5525 | 0.8141 | 1.1315 | 1.1903 | 1.533 | 1.3885 | 1.3046 | 0.7839 | 0.7893 | 0.7312 | 0.7383 | 0.7 |
Gilead Sciences and related stocks such as Amgen Inc, Merck Company, and AbbVie Inc Debt To Equity description
A measure of a company's financial leverage calculated by dividing its total liabilities by stockholders' equity, indicating the proportion of equity and debt the company is using to finance its assets.My Equities
My Current Equities and Potential Positions
| Gilead Sciences | GILD |
| Classification | Macroaxis Index |
| Location | California; U.S.A |
| Exchange | NASDAQ Exchange |
USD 111.53
Check out Gilead Sciences Performance and Gilead Sciences Correlation. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.